BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 33771552)

  • 1. Functional and structural analysis of cytokine-selective IL6ST defects that cause recessive hyper-IgE syndrome.
    Chen YH; Zastrow DB; Metcalfe RD; Gartner L; Krause F; Morton CJ; Marwaha S; Fresard L; Huang Y; Zhao C; McCormack C; Bick D; Worthey EA; Eng CM; Gold J; Undiagnosed Diseases Network ; Montgomery SB; Fisher PG; Ashley EA; Wheeler MT; Parker MW; Shanmugasundaram V; Putoczki TL; Schmidt-Arras D; Laurence A; Bernstein JA; Griffin MDW; Uhlig HH
    J Allergy Clin Immunol; 2021 Aug; 148(2):585-598. PubMed ID: 33771552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Human GP130 Cytokine Receptor and Its Expression-an Atlas and Functional Taxonomy of Genetic Variants.
    Chen YH; van Zon S; Adams A; Schmidt-Arras D; Laurence ADJ; Uhlig HH
    J Clin Immunol; 2023 Dec; 44(1):30. PubMed ID: 38133879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A biallelic mutation in
    Schwerd T; Twigg SRF; Aschenbrenner D; Manrique S; Miller KA; Taylor IB; Capitani M; McGowan SJ; Sweeney E; Weber A; Chen L; Bowness P; Riordan A; Cant A; Freeman AF; Milner JD; Holland SM; Frede N; Müller M; Schmidt-Arras D; Grimbacher B; Wall SA; Jones EY; Wilkie AOM; Uhlig HH
    J Exp Med; 2017 Sep; 214(9):2547-2562. PubMed ID: 28747427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective loss of function variants in
    Shahin T; Aschenbrenner D; Cagdas D; Bal SK; Conde CD; Garncarz W; Medgyesi D; Schwerd T; Karaatmaca B; Cetinkaya PG; Esenboga S; Twigg SRF; Cant A; Wilkie AOM; Tezcan I; Uhlig HH; Boztug K
    Haematologica; 2019 Mar; 104(3):609-621. PubMed ID: 30309848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New Dominant-Negative IL6ST Variants Expand the Immunological and Clinical Spectrum of GP130-Dependent Hyper-IgE Syndrome.
    Arlabosse T; Materna M; Riccio O; Schnider C; Angelini F; Perreau M; Rochat I; Superti-Furga A; Campos-Xavier B; Héritier S; Pereira A; Deswarte C; Lévy R; Distefano M; Bustamante J; Roelens M; Borie R; Le Brun M; Crestani B; Casanova JL; Puel A; Hofer M; Fieschi C; Theodoropoulou K; Béziat V; Candotti F
    J Clin Immunol; 2023 Oct; 43(7):1566-1580. PubMed ID: 37273120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absence of GP130 cytokine receptor signaling causes extended Stüve-Wiedemann syndrome.
    Chen YH; Grigelioniene G; Newton PT; Gullander J; Elfving M; Hammarsjö A; Batkovskyte D; Alsaif HS; Kurdi WIY; Abdulwahab F; Shanmugasundaram V; Devey L; Bacrot S; Brodszki J; Huber C; Hamel B; Gisselsson D; Papadogiannakis N; Jedrycha K; Gürtl-Lackner B; Chagin AS; Nishimura G; Aschenbrenner D; Alkuraya FS; Laurence A; Cormier-Daire V; Uhlig HH
    J Exp Med; 2020 Mar; 217(3):. PubMed ID: 31914175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dominant-negative mutations in human IL6ST underlie hyper-IgE syndrome.
    Béziat V; Tavernier SJ; Chen YH; Ma CS; Materna M; Laurence A; Staal J; Aschenbrenner D; Roels L; Worley L; Claes K; Gartner L; Kohn LA; De Bruyne M; Schmitz-Abe K; Charbonnier LM; Keles S; Nammour J; Vladikine N; Maglorius Renkilaraj MRL; Seeleuthner Y; Migaud M; Rosain J; Jeljeli M; Boisson B; Van Braeckel E; Rosenfeld JA; Dai H; Burrage LC; Murdock DR; Lambrecht BN; Avettand-Fenoel V; Vogel TP; ; Esther CR; Haskologlu S; Dogu F; Ciznar P; Boutboul D; Ouachée-Chardin M; Amourette J; Lebras MN; Gauvain C; Tcherakian C; Ikinciogullari A; Beyaert R; Abel L; Milner JD; Grimbacher B; Couderc LJ; Butte MJ; Freeman AF; Catherinot É; Fieschi C; Chatila TA; Tangye SG; Uhlig HH; Haerynck F; Casanova JL; Puel A
    J Exp Med; 2020 Jun; 217(6):. PubMed ID: 32207811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mosaic IL6ST variant inducing constitutive GP130 cytokine receptor signaling as a cause of neonatal onset immunodeficiency with autoinflammation and dysmorphy.
    Materna-Kiryluk A; Pollak A; Gawalski K; Szczawinska-Poplonyk A; Rydzynska Z; Sosnowska A; Cukrowska B; Gasperowicz P; Konopka E; Pietrucha B; Grzywa TM; Banaszak-Ziemska M; Niedziela M; Skalska-Sadowska J; Stawiński P; Śladowski D; Nowis D; Ploski R
    Hum Mol Genet; 2021 Apr; 30(3-4):226-233. PubMed ID: 33517393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural organization of a full-length gp130/LIF-R cytokine receptor transmembrane complex.
    Skiniotis G; Lupardus PJ; Martick M; Walz T; Garcia KC
    Mol Cell; 2008 Sep; 31(5):737-48. PubMed ID: 18775332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A variant in
    Schwerd T; Krause F; Twigg SRF; Aschenbrenner D; Chen YH; Borgmeyer U; Müller M; Manrique S; Schumacher N; Wall SA; Jung J; Damm T; Glüer CC; Scheller J; Rose-John S; Jones EY; Laurence A; Wilkie AOM; Schmidt-Arras D; Uhlig HH
    Bone Res; 2020; 8():24. PubMed ID: 32566365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A functional role of the membrane-proximal extracellular domains of the signal transducer gp130 in heterodimerization with the leukemia inhibitory factor receptor.
    Timmermann A; Küster A; Kurth I; Heinrich PC; Müller-Newen G
    Eur J Biochem; 2002 Jun; 269(11):2716-26. PubMed ID: 12047380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The amino acid exchange R28E in ciliary neurotrophic factor (CNTF) abrogates interleukin-6 receptor-dependent but retains CNTF receptor-dependent signaling via glycoprotein 130 (gp130)/leukemia inhibitory factor receptor (LIFR).
    Wagener EM; Aurich M; Aparicio-Siegmund S; Floss DM; Garbers C; Breusing K; Rabe B; Schwanbeck R; Grötzinger J; Rose-John S; Scheller J
    J Biol Chem; 2014 Jun; 289(26):18442-50. PubMed ID: 24802752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyper-IgE syndrome, 2021 update.
    Minegishi Y
    Allergol Int; 2021 Oct; 70(4):407-414. PubMed ID: 34419355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contributions of leukemia inhibitory factor receptor and oncostatin M receptor to signal transduction in heterodimeric complexes with glycoprotein 130.
    Hermanns HM; Radtke S; Haan C; Schmitz-Van de Leur H; Tavernier J; Heinrich PC; Behrmann I
    J Immunol; 1999 Dec; 163(12):6651-8. PubMed ID: 10586060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative study of gp130 cytokine effects on corticotroph AtT-20 cells--redundancy or specificity of neuroimmunoendocrine modulators?
    Auernhammer CJ; Kopp FB; Vlotides G; Dorn F; Isele NB; Spöttl G; Cengic N; Weber MM; Senaldi G; Engelhardt D
    Neuroimmunomodulation; 2004; 11(4):224-32. PubMed ID: 15249728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low incidence of IL6ST (gp130) mutations in exon 6 in lung cancer of a Chinese cohort.
    Sun L; Sui L; Cong X; Ma K; Ma X; Huang Y; Fan C; Fu X; Ma K
    Cancer Genet; 2014; 207(7-8):291-8. PubMed ID: 25242236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progesterone and interferon tau regulate leukemia inhibitory factor receptor and IL6ST in the ovine uterus during early pregnancy.
    Song G; Satterfield MC; Kim J; Bazer FW; Spencer TE
    Reproduction; 2009 Mar; 137(3):553-65. PubMed ID: 19060097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inborn errors of IL-6 family cytokine responses.
    Chen YH; Spencer S; Laurence A; Thaventhiran JE; Uhlig HH
    Curr Opin Immunol; 2021 Oct; 72():135-145. PubMed ID: 34044328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual oncostatin M (OSM) receptors. Cloning and characterization of an alternative signaling subunit conferring OSM-specific receptor activation.
    Mosley B; De Imus C; Friend D; Boiani N; Thoma B; Park LS; Cosman D
    J Biol Chem; 1996 Dec; 271(51):32635-43. PubMed ID: 8999038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of glycoprotein 130 family of cytokines in fetal rat lung development.
    Nogueira-Silva C; Piairo P; Carvalho-Dias E; Veiga C; Moura RS; Correia-Pinto J
    PLoS One; 2013; 8(6):e67607. PubMed ID: 23826327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.